Blackstone Inc’s Jade Biosciences JBIO Stock Holding History

Blackstone Inc’s Portfolio JBIO Stock Details JBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-27,289	Closed	-$2.4M	–	175
2025 Q1	$2.4M	Buy	27,289 +13,016	+91%	+$1.14M	0.01%	111
2024 Q4	$1.32M	Buy	+14,273	New	+$1.23M	0.01%	120

Other funds holding JBIO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Blackstone Inc's JBIO Position: Q2 2025 in Review

Blackstone Inc sold out of Jade Biosciences (JBIO) in Q2 2025, closing a stake of 27,289 shares — an estimated $2.4M sold.

Blackstone Inc first reported a position in JBIO in Q4 2024 and held it in 2 quarters. The position peaked at $2.4M in Q1 2025. 75 funds tracked by Wall St. Rank hold JBIO as of Q2 2025.

Blackstone Inc reported no remaining Jade Biosciences position as of Q2 2025 after selling out during the quarter.
Blackstone Inc sold 27,289 Jade Biosciences shares in Q2 2025, an estimated $2.4M.
Blackstone Inc first reported a position in Jade Biosciences in Q4 2024 and held it in 2 quarters.
Blackstone Inc's Jade Biosciences position peaked at $2.4M in Q1 2025.
75 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2025.

Based on Blackstone Inc's 13F filing for Q2 2025, filed 14 Aug 2025.